CHARDES; Thierry

Patent Applications and Registrations

Patent applications and USPTO patent grants for CHARDES; Thierry.The latest application filed is for "use of mullerian inhibiting substance inhibitors for treating cancer".

Company Profile

2.12.14

CHARDES; Thierry - Montpellier FR
Chardes; Thierry - Assas FR
Chardes; Thierry - Montpellier Cedex 5 FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Mullerian Inhibiting Substance Inhibitors For Treating Cancer App 20220290151 - PELEGRIN; Andre ; et al.	2022-09-15
Anti-human-HER3 antibodies and uses thereof Grant 11,001,634 - Chardes , et al. May 11, 2	2021-05-11
Human monoclonal antibodies fragments inhibiting both the Cath-D catalytic activity and its binding to the LRP1 receptor Grant 10,526,415 - Liaudet-Coopman , et al. J	2020-01-07
Neuregulin allosteric anti-HER3 antibody Grant 10,196,455 - Chardes , et al. Fe	2019-02-05
Anti-nrg1 (heregulin) Antibodies And Uses Thereof App 20180291098 - Ogier; Charline ; et al.	2018-10-11
Human Monoclonal Antibodies Fragments Inhibiting Both The Cath-d Catalytic Activity And Its Binding To The Lrp1 Receptor App 20180127510 - LIAUDET-COOPMAN; Emmanuelle ; et al.	2018-05-10
Neuregulin Allosteric Anti-HER3 Antibody App 20160319033 - Chardes; Thierry ; et al.	2016-11-03
Anti-Axl antibodies and uses thereof Grant 9,409,988 - Robert , et al. August 9, 2	2016-08-09
Antibodies against HER3 Grant 9,346,883 - Kharrat , et al. May 24, 2	2016-05-24
Anti-Axl antibodies and uses thereof Grant 9,249,228 - Robert , et al. February 2, 2	2016-02-02
Anti-human HER3 antibodies and uses thereof Grant 9,127,065 - Chardes , et al. September 8, 2	2015-09-08
Anti-axl Antibodies And Uses Thereof App 20140302041 - Robert; Bruno ; et al.	2014-10-09
Anti-axl Antibodies And Uses Thereof App 20140227283 - Robert; Bruno ; et al.	2014-08-14
Antibodies Against Her3 App 20140141019 - Kharrat; Abdelhakim ; et al.	2014-05-22
Anti-human Her3 Antibodies And Uses Thereof App 20140112931 - Chardes; Thierry ; et al.	2014-04-24
Mutant Fab fragments of the chimeric 13B8.2 anti-CD4 antibody and their applications Grant 7,482,000 - Devaux , et al. January 27, 2	2009-01-27
Mutant fab fragments of the chimeric 13B8.2 anti-CD4 antibody and their applications App 20050226874 - Devaux, Christian ; et al.	2005-10-13
CDR-H1-derived peptide CB11, pharmaceutical compositions made therefrom and methods of treating disorders in mammals App 20030113322 - Bes, Cedric ; et al.	2003-06-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.